NDC Code | 63479-0207-1 |
Package Description | 30 mL in 1 BOTTLE, GLASS (63479-0207-1) |
Product NDC | 63479-0207 |
Product Type Name | HUMAN OTC DRUG |
Proprietary Name | B07 |
Proprietary Name Suffix | Dprsn Antitox |
Non-Proprietary Name | Adrenalinum, Aethusa Cynapium, Agnus Castus, Alfalfa, Argentum Nitricum, Aurum Metallicum, Avena Sativa, Ceratostigma Willmottianum Flower, Cherry Plum Flower, Damiana, European Aspen Flower, European Hornbeam Flower, Gorse Flower, Hypericum Perforatum, Kali Phosphoricum, Lycopodium Clavatum, Mandragora Officinarum, Natrum Muriaticum, Passiflora Incarnata, Rosa Canina Flower, Sepia, Sweet Chestnut Flower, Thyroidinum, Wild Mustard Flower |
Dosage Form | SOLUTION/ DROPS |
Usage | SUBLINGUAL |
Start Marketing Date | 19970715 |
Marketing Category Name | UNAPPROVED HOMEOPATHIC |
Manufacturer | Apex Energetics Inc. |
Substance Name | AETHUSA CYNAPIUM; ALFALFA; AVENA SATIVA FLOWERING TOP; CARPINUS BETULUS FLOWER; CASTANEA SATIVA FLOWER; CERATOSTIGMA WILLMOTTIANUM FLOWER; CHASTE TREE; EPINEPHRINE; GOLD; HYPERICUM PERFORATUM; LYCOPODIUM CLAVATUM SPORE; MANDRAGORA OFFICINARUM ROOT; PASSIFLORA INCARNATA FLOWERING TOP; POPULUS TREMULA FLOWERING TOP; POTASSIUM PHOSPHATE, DIBASIC; PRUNUS CERASIFERA FLOWER; ROSA CANINA FLOWER; SEPIA OFFICINALIS JUICE; SILVER NITRATE; SINAPIS ARVENSIS FLOWERING/FRUITING TOP; SODIUM CHLORIDE; THYROID, UNSPECIFIED; TURNERA DIFFUSA LEAFY TWIG; ULEX EUROPAEUS FLOWER |
Strength | 30; 1; 1; 15; 15; 30; 2; 6; 30; 3; 60; 30; 1; 30; 30; 15; 15; 30; 30; 15; 30; 6; 1; 30 |
Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL |
Pharmacy Classes | Adrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Potassium Compounds [CS], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] |